CG Oncology (CGON) News Today $24.49 -1.93 (-7.31%) Closing price 04:00 PM EasternExtended Trading$24.50 +0.01 (+0.02%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Analysts Offer Insights on NA Companies: Nano Nuclear Energy Inc. (NNE) and CG Oncology, Inc. (CGON)March 31 at 9:14 PM | markets.businessinsider.comCG Oncology, Inc. (CGON) Gets a Buy from Morgan StanleyMarch 31 at 9:14 PM | markets.businessinsider.comBuy Rating for CG Oncology, Inc. Driven by Promising Developments in Bladder Cancer TreatmentMarch 31 at 5:30 AM | tipranks.comCG Oncology reports FY24 EPS ($1.41) vs ($15.65) last yearMarch 29 at 12:14 AM | markets.businessinsider.comCG Oncology files automatic mixed securities shelfMarch 29 at 12:14 AM | markets.businessinsider.comCG Oncology Advances in Bladder Cancer TherapeuticsMarch 29 at 12:06 AM | tipranks.comCG Oncology announces mixed shelf offeringMarch 28 at 7:08 PM | msn.comCG Oncology Reports 2024 Year End Financial Results and Provides Business UpdatesMarch 28 at 7:08 PM | markets.businessinsider.comCG Oncology, Inc. GAAP EPS of -$0.46March 28 at 12:50 PM | seekingalpha.comSwiss National Bank Has $2.28 Million Position in CG Oncology, Inc. (NASDAQ:CGON)Swiss National Bank lifted its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 144.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 79,600 shares of the company's stock after buying an additional 47,000 shares during the perioMarch 28 at 3:30 AM | marketbeat.comExpert Outlook: CG Oncology Through The Eyes Of 4 AnalystsMarch 27, 2025 | nasdaq.comCG Oncology's (CGON) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and issued a $75.00 price objective on shares of CG Oncology in a report on Tuesday.March 26, 2025 | marketbeat.comFirst Week of CGON May 16th Options TradingMarch 26, 2025 | nasdaq.comCG Oncology says 75.5% of patients achieve CR in Phase 3 study of cretostimogeneMarch 26, 2025 | markets.businessinsider.com4CGON : Expert Outlook: CG Oncology Through The Eyes Of 4 AnalystsMarch 25, 2025 | benzinga.comIntech Investment Management LLC Acquires New Shares in CG Oncology, Inc. (NASDAQ:CGON)Intech Investment Management LLC acquired a new position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 16,787 shares of the company's stock, valMarch 25, 2025 | marketbeat.comCG Oncology’s Promising Phase 3 Trial Results RevealedMarch 24, 2025 | tipranks.comCretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and EfficacyMarch 24, 2025 | globenewswire.comiA Global Asset Management Inc. Takes Position in CG Oncology, Inc. (NASDAQ:CGON)iA Global Asset Management Inc. bought a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 45,890 shares of the company's stock, valued at approximaMarch 23, 2025 | marketbeat.comCG Oncology (CGON) Expected to Announce Earnings on TuesdayMarch 23, 2025 | americanbankingnews.comCG Oncology, Inc. (NASDAQ:CGON) Shares Bought by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 12.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 427,760 shares of the company's stock after buying an additional 48,096 shares during theMarch 22, 2025 | marketbeat.comBank of New York Mellon Corp Decreases Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON)Bank of New York Mellon Corp decreased its holdings in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 135,567 shares ofMarch 19, 2025 | marketbeat.comCG Oncology (CGON) Expected to Announce Quarterly Earnings on TuesdayCG Oncology (NASDAQ:CGON) will be releasing earnings before the market opens on Tuesday, March 25, Financial Modeling Prep reports.March 18, 2025 | marketbeat.com11,853 Shares in CG Oncology, Inc. (NASDAQ:CGON) Purchased by Arizona State Retirement SystemArizona State Retirement System purchased a new stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 11,853 shares of the company's stock, valued at approximately $340,000. Other hedge fMarch 16, 2025 | marketbeat.comCG Oncology (NASDAQ:CGON) Shares Up 7.3% - What's Next?CG Oncology (NASDAQ:CGON) Stock Price Up 7.3% - Still a Buy?March 15, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Receives Average Recommendation of "Buy" from BrokeragesCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has been given an average recommendation of "Buy" by the ten research firms that are currently covering the firm, MarketBeat.com reports. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company.March 15, 2025 | marketbeat.comCG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and UpdatesMarch 12, 2025 | markets.businessinsider.comCG Oncology (NASDAQ:CGON) Given Overweight Rating at Morgan StanleyMorgan Stanley reaffirmed an "overweight" rating and set a $55.00 price target on shares of CG Oncology in a research note on Friday.March 8, 2025 | marketbeat.comCG Oncology assumed with an Overweight at Morgan StanleyMarch 7, 2025 | markets.businessinsider.comCG Oncology (NASDAQ:CGON) Reaches New 52-Week Low - Here's WhyCG Oncology (NASDAQ:CGON) Sets New 12-Month Low - What's Next?March 5, 2025 | marketbeat.comHandelsbanken Fonder AB Takes $381,000 Position in CG Oncology, Inc. (NASDAQ:CGON)Handelsbanken Fonder AB purchased a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 13,300 shares of the company's stock, valued at approximately $381,000. Several other large investoMarch 3, 2025 | marketbeat.comCG Oncology to Present at the TD Cowen 45th Annual Health Care ConferenceFebruary 26, 2025 | globenewswire.comCG Oncology (NASDAQ:CGON) Sets New 12-Month Low - Time to Sell?CG Oncology (NASDAQ:CGON) Sets New 1-Year Low - Here's WhyFebruary 25, 2025 | marketbeat.comTimesSquare Capital Management LLC Acquires 109,835 Shares of CG Oncology, Inc. (NASDAQ:CGON)TimesSquare Capital Management LLC raised its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 25.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 546,904 shares of the company's stock after purchFebruary 20, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Sees Large Growth in Short InterestCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) saw a large growth in short interest in January. As of January 31st, there was short interest totalling 6,780,000 shares, a growth of 6.4% from the January 15th total of 6,370,000 shares. Based on an average daily volume of 697,900 shares, the short-interest ratio is presently 9.7 days. Currently, 15.2% of the company's stock are short sold.February 19, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Given Consensus Rating of "Buy" by AnalystsCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has been given a consensus rating of "Buy" by the ten analysts that are covering the company, MarketBeat reports. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month tFebruary 18, 2025 | marketbeat.comCG Oncology, Inc. (CGON) Gets a Buy from Bank of America SecuritiesFebruary 13, 2025 | markets.businessinsider.comCG Oncology, Inc. (NASDAQ:CGON) is a favorite amongst institutional investors who own 62%February 3, 2025 | finance.yahoo.comChina Universal Asset Management Co. Ltd. Makes New Investment in CG Oncology, Inc. (NASDAQ:CGON)China Universal Asset Management Co. Ltd. acquired a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 14,340 shares of the company's stock, valued at approxiFebruary 3, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Stock Holdings Boosted by JPMorgan Chase & Co.JPMorgan Chase & Co. boosted its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 59.1% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 31,071 shares of the company's stock after purchasing an additJanuary 25, 2025 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Receives Average Recommendation of "Buy" from AnalystsCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has been assigned a consensus rating of "Buy" from the ten research firms that are presently covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendatJanuary 24, 2025 | marketbeat.comCantor Fitzgerald Forecasts CG Oncology FY2025 EarningsCG Oncology, Inc. (NASDAQ:CGON - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for CG Oncology in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will postJanuary 23, 2025 | marketbeat.comInsider Selling: CG Oncology, Inc. (NASDAQ:CGON) Director Sells 1,000 Shares of StockJanuary 15, 2025 | insidertrades.comCG Oncology, Inc. (NASDAQ:CGON) Director Leonard E. Post Sells 1,000 SharesCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) Director Leonard E. Post sold 1,000 shares of CG Oncology stock in a transaction dated Monday, January 13th. The shares were sold at an average price of $29.66, for a total value of $29,660.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.January 14, 2025 | marketbeat.comA First Take On CG OncologyJanuary 11, 2025 | seekingalpha.comPfizer study impact on CG Oncology to be minimal, says H.C. WainwrightJanuary 10, 2025 | markets.businessinsider.comCG Oncology Amends Key Executive Employment AgreementsJanuary 10, 2025 | tipranks.comCG Oncology (NASDAQ:CGON) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and set a $75.00 price objective on shares of CG Oncology in a report on Friday.January 10, 2025 | marketbeat.comCG Oncology initiated with a Buy at TD CowenJanuary 8, 2025 | markets.businessinsider.comCG Oncology, Inc. (CGON) Receives a Buy from TD CowenJanuary 8, 2025 | markets.businessinsider.com Remove Ads Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address CGON Media Mentions By Week CGON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGON News Sentiment▼0.420.82▲Average Medical News Sentiment CGON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGON Articles This Week▼204▲CGON Articles Average Week Remove Ads Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Roivant Sciences News Today Sarepta Therapeutics News Today Revolution Medicines News Today Lantheus News Today TG Therapeutics News Today Legend Biotech News Today BridgeBio Pharma News Today Axsome Therapeutics News Today Telix Pharmaceuticals Limited American Depositary Shares News Today Blueprint Medicines News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGON) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
